Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancer (Q36542491)
Jump to navigation
Jump to search
scientific article published on July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancer |
scientific article published on July 2006 |
Statements
1 reference
Rationale for a phase II trial of pertuzumab, a HER-2 dimerization inhibitor, in patients with non-small cell lung cancer (English)
1 reference
Pasi A Jänne
1 reference
Bruce E Johnson
1 reference
1 reference
Identifiers
1 reference